216 related articles for article (PubMed ID: 23917726)
1. Galectin-3 inhibition sensitizes human renal cell carcinoma cells to arsenic trioxide treatment.
Xu Y; Gu X; Gong M; Guo G; Han K; An R
Cancer Biol Ther; 2013 Oct; 14(10):897-906. PubMed ID: 23917726
[TBL] [Abstract][Full Text] [Related]
2. Ethacrynic acid and a derivative enhance apoptosis in arsenic trioxide-treated myeloid leukemia and lymphoma cells: the role of glutathione S-transferase p1-1.
Wang R; Liu C; Xia L; Zhao G; Gabrilove J; Waxman S; Jing Y
Clin Cancer Res; 2012 Dec; 18(24):6690-701. PubMed ID: 23082001
[TBL] [Abstract][Full Text] [Related]
3. Arsenic trioxide induces autophagy and apoptosis in human glioma cells in vitro and in vivo through downregulation of survivin.
Chiu HW; Ho YS; Wang YJ
J Mol Med (Berl); 2011 Sep; 89(9):927-41. PubMed ID: 21594580
[TBL] [Abstract][Full Text] [Related]
4. ROS-mediated endoplasmic reticulum stress and mitochondrial dysfunction underlie apoptosis induced by resveratrol and arsenic trioxide in A549 cells.
Gu S; Chen C; Jiang X; Zhang Z
Chem Biol Interact; 2016 Feb; 245():100-9. PubMed ID: 26772155
[TBL] [Abstract][Full Text] [Related]
5. Epoxyeicosatrienoic acids attenuate reactive oxygen species level, mitochondrial dysfunction, caspase activation, and apoptosis in carcinoma cells treated with arsenic trioxide.
Liu L; Chen C; Gong W; Li Y; Edin ML; Zeldin DC; Wang DW
J Pharmacol Exp Ther; 2011 Nov; 339(2):451-63. PubMed ID: 21846841
[TBL] [Abstract][Full Text] [Related]
6. Quercetin decreases intracellular GSH content and potentiates the apoptotic action of the antileukemic drug arsenic trioxide in human leukemia cell lines.
Ramos AM; Aller P
Biochem Pharmacol; 2008 May; 75(10):1912-23. PubMed ID: 18359480
[TBL] [Abstract][Full Text] [Related]
7. Combined arsenic trioxide-cisplatin treatment enhances apoptosis in oral squamous cell carcinoma cells.
Nakaoka T; Ota A; Ono T; Karnan S; Konishi H; Furuhashi A; Ohmura Y; Yamada Y; Hosokawa Y; Kazaoka Y
Cell Oncol (Dordr); 2014 Apr; 37(2):119-29. PubMed ID: 24599717
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of Mcl-1 through GSK-3β activation contributes to arsenic trioxide-induced apoptosis in acute myeloid leukemia cells.
Wang R; Xia L; Gabrilove J; Waxman S; Jing Y
Leukemia; 2013 Feb; 27(2):315-24. PubMed ID: 22751450
[TBL] [Abstract][Full Text] [Related]
9. Arsenic trioxide induces oxidative stress, DNA damage, and mitochondrial pathway of apoptosis in human leukemia (HL-60) cells.
Kumar S; Yedjou CG; Tchounwou PB
J Exp Clin Cancer Res; 2014 May; 33(1):42. PubMed ID: 24887205
[TBL] [Abstract][Full Text] [Related]
10. Combination of arsenic trioxide and chemotherapy in small cell lung cancer.
Zheng CY; Lam SK; Li YY; Fong BM; Mak JC; Ho JC
Lung Cancer; 2013 Nov; 82(2):222-30. PubMed ID: 24041618
[TBL] [Abstract][Full Text] [Related]
11. Alteration in miRNA gene expression pattern in acute promyelocytic leukemia cell induced by arsenic trioxide: a possible mechanism to explain arsenic multi-target action.
Ghaffari SH; Bashash D; Dizaji MZ; Ghavamzadeh A; Alimoghaddam K
Tumour Biol; 2012 Feb; 33(1):157-72. PubMed ID: 22072212
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of mitochondrial protein translation sensitizes melanoma cells to arsenic trioxide cytotoxicity via a reactive oxygen species dependent mechanism.
Bowling BD; Doudican N; Manga P; Orlow SJ
Cancer Chemother Pharmacol; 2008 Dec; 63(1):37-43. PubMed ID: 18297286
[TBL] [Abstract][Full Text] [Related]
13. Sustained activation of c-jun-N-terminal kinase plays a critical role in arsenic trioxide-induced cell apoptosis in multiple myeloma cell lines.
Kajiguchi T; Yamamoto K; Iida S; Ueda R; Emi N; Naoe T
Cancer Sci; 2006 Jun; 97(6):540-5. PubMed ID: 16734734
[TBL] [Abstract][Full Text] [Related]
14. Low-dose arsenic trioxide sensitizes glucocorticoid-resistant acute lymphoblastic leukemia cells to dexamethasone via an Akt-dependent pathway.
Bornhauser BC; Bonapace L; Lindholm D; Martinez R; Cario G; Schrappe M; Niggli FK; Schäfer BW; Bourquin JP
Blood; 2007 Sep; 110(6):2084-91. PubMed ID: 17537996
[TBL] [Abstract][Full Text] [Related]
15. Galectin-3 as a marker and potential therapeutic target in breast cancer.
Zhang H; Luo M; Liang X; Wang D; Gu X; Duan C; Gu H; Chen G; Zhao X; Zhao Z; Liu C
PLoS One; 2014; 9(9):e103482. PubMed ID: 25254965
[TBL] [Abstract][Full Text] [Related]
16. The optimal dose of arsenic trioxide induced opposite efficacy in autophagy between K562 cells and their initiating cells to eradicate human myelogenous leukemia.
Guo Z; Meng M; Geng S; Du Z; Zheng Y; Yao J; Li Z; Han G; Lin H; Du G
J Ethnopharmacol; 2017 Jan; 196():29-38. PubMed ID: 27965050
[TBL] [Abstract][Full Text] [Related]
17. Arsenic trioxide and cisplatin synergism increase cytotoxicity in human ovarian cancer cells: therapeutic potential for ovarian cancer.
Zhang N; Wu ZM; McGowan E; Shi J; Hong ZB; Ding CW; Xia P; Di W
Cancer Sci; 2009 Dec; 100(12):2459-64. PubMed ID: 19769630
[TBL] [Abstract][Full Text] [Related]
18. Increased apoptotic efficacy of lonidamine plus arsenic trioxide combination in human leukemia cells. Reactive oxygen species generation and defensive protein kinase (MEK/ERK, Akt/mTOR) modulation.
Calviño E; Estañ MC; Simón GP; Sancho P; Boyano-Adánez Mdel C; de Blas E; Bréard J; Aller P
Biochem Pharmacol; 2011 Dec; 82(11):1619-29. PubMed ID: 21889928
[TBL] [Abstract][Full Text] [Related]
19. Arsenic trioxide-induced cytotoxicity in small cell lung cancer via altered redox homeostasis and mitochondrial integrity.
Zheng CY; Lam SK; Li YY; Ho JC
Int J Oncol; 2015 Mar; 46(3):1067-78. PubMed ID: 25572414
[TBL] [Abstract][Full Text] [Related]
20. Dihydroartemisinin Sensitizes Human Lung Adenocarcinoma A549 Cells to Arsenic Trioxide via Apoptosis.
Chen H; Gu S; Dai H; Li X; Zhang Z
Biol Trace Elem Res; 2017 Oct; 179(2):203-212. PubMed ID: 28261759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]